Neuroinflammatory Markers in the Serum of Prepubertal Children with Down Syndrome

Luigi Tarani1, Valentina Carito2, Giampiero Ferraguti3

  • 1Department of Pediatrics, Sapienza University Hospital of Rome, Italy.

Insights

This study found higher brain-derived neurotrophic factor (BDNF) in children with Down syndrome (DS). However, they showed decreased serum cytokines, indicating immune system pathway disruptions in young DS individuals.

Area of Science:

  • Neuroscience
  • Immunology
  • Genetics

Background:

  • Down syndrome (DS) is the most common chromosomal disorder, often associated with physical and cognitive features.
  • While immune dysregulation is known in adults with DS, limited data exists on neuroinflammation in prepubertal DS children.

Purpose of the Study:

  • To assess serum levels of neurotrophins (NGF, BDNF) and immune markers in prepubertal children with DS.
  • To investigate oxidative stress markers (FORD, FORT) and key cytokines involved in neuroinflammation.

Main Methods:

  • Serum samples from prepubertal DS children and controls were analyzed.
  • Levels of NGF, BDNF, FORD, FORT, and various cytokines (TNF-α, TGF-β, MCP-1, IL-1α, IL-2, IL-6, IL-10, IL-12) were measured.

Main Results:

  • No significant difference in NGF levels was observed between DS children and controls.
  • BDNF levels were higher in DS children compared to controls.
  • No changes in FORD and FORT were detected. A marked decrease in all analyzed cytokines was found in DS children, with sex-based differences noted.

Conclusions:

  • Prepubertal children with Down syndrome exhibit altered neurotrophin profiles, specifically elevated BDNF.
  • The study reveals significant disruptions in immune system pathways and cytokine profiles in young DS individuals.
  • These findings highlight neuroinflammation and immune dysregulation as key aspects in early development of Down syndrome.

Related Concept Videos